CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION AND ATTENUATION OF MEASLES

^{Department of Bacteriology and Immunology, Harvard Medical School and School of Public Health, and the Children's and the Infants' Hospitals, Boston}

^{Department of Pediatrics, Harvard Medical School and School of Public Health, and the Children's and the Infants' Hospitals, Boston}

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 19 in the series “Studies on Plasma Proteins” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Ordman, C. in: PubMed | Google Scholar

^{Department of Bacteriology and Immunology, Harvard Medical School and School of Public Health, and the Children's and the Infants' Hospitals, Boston}

^{Department of Pediatrics, Harvard Medical School and School of Public Health, and the Children's and the Infants' Hospitals, Boston}

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 19 in the series “Studies on Plasma Proteins” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Jennings, C. in: PubMed | Google Scholar

^{Department of Bacteriology and Immunology, Harvard Medical School and School of Public Health, and the Children's and the Infants' Hospitals, Boston}

^{Department of Pediatrics, Harvard Medical School and School of Public Health, and the Children's and the Infants' Hospitals, Boston}

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 19 in the series “Studies on Plasma Proteins” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Janeway, C. in: PubMed | Google Scholar